These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 31213766)

  • 1. SU5416 attenuated lipopolysaccharide-induced acute lung injury in mice by modulating properties of vascular endothelial cells.
    Huang X; Zhu J; Jiang Y; Xu C; Lv Q; Yu D; Shi K; Ruan Z; Wang Y
    Drug Des Devel Ther; 2019; 13():1763-1772. PubMed ID: 31213766
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
    Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
    Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
    Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
    Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of TFPI-Anchored Endothelial Cells Exacerbates Lipopolysaccharide-Induced Acute Lung Injury Via NF-κB Signaling Pathway.
    Wang BQ; Shi M; Zhang JP; Wu X; Chang MJ; Chen ZH; Shen HH; Song YL; Zhou J; Bai CX
    Shock; 2019 Feb; 51(2):235-246. PubMed ID: 29438223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EphA2 antagonism alleviates LPS-induced acute lung injury via Nrf2/HO-1, TLR4/MyD88 and RhoA/ROCK pathways.
    Feng G; Sun B; Liu HX; Liu QH; Zhao L; Wang TL
    Int Immunopharmacol; 2019 Jul; 72():176-185. PubMed ID: 30986645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP18 mitigates lipopolysaccharide-induced oxidative stress and inflammation in human pulmonary microvascular endothelial cells through the TLR4/NF-κB/ROS signaling.
    Jiang Z; Shen J; Ding J; Yuan Y; Gao L; Yang Z; Zhao X
    Toxicol In Vitro; 2021 Sep; 75():105181. PubMed ID: 33930521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by suppressing TLR4 signaling.
    Wu Y; Wang Y; Gong S; Tang J; Zhang J; Li F; Yu B; Zhang Y; Kou J
    Biomed Pharmacother; 2020 May; 125():109868. PubMed ID: 32036210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferulic acid alleviates lipopolysaccharide-induced acute lung injury through inhibiting TLR4/NF-κB signaling pathway.
    Wu X; Lin L; Wu H
    J Biochem Mol Toxicol; 2021 Mar; 35(3):e22664. PubMed ID: 33140555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-κB pathway.
    Liu JX; Li X; Yan FG; Pan QJ; Yang C; Wu MY; Li G; Liu HF
    Int Immunopharmacol; 2019 Jan; 66():336-346. PubMed ID: 30521962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effects of Mai-Luo-Ning injection against LPS-induced acute lung injury via the TLR4/NF-κB signalling pathway.
    Miao J; Shen J; Yan C; Ren J; Liu H; Qiao Y; Li Q
    Phytomedicine; 2022 Sep; 104():154290. PubMed ID: 35793597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dioscin alleviates lipopolysaccharide-induced acute lung injury through suppression of TLR4 signaling pathways.
    Wang C; Li Q; Li T
    Exp Lung Res; 2020; 46(1-2):11-22. PubMed ID: 31931639
    [No Abstract]   [Full Text] [Related]  

  • 14. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.
    Luo Y; Che W; Zhao M
    Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saquinavir plus methylprednisolone ameliorates experimental acute lung injury.
    Zhang G; Zhang X; Huang H; Ji Y; Li D; Jiang W
    Braz J Med Biol Res; 2018 Aug; 51(10):e7579. PubMed ID: 30088541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gypenosides Inhibit Inflammatory Response and Apoptosis of Endothelial and Epithelial Cells in LPS-Induced ALI: A Study Based on Bioinformatic Analysis and in vivo/vitro Experiments.
    Tu Q; Zhu Y; Yuan Y; Guo L; Liu L; Yao L; Zou Y; Li J; Chen F
    Drug Des Devel Ther; 2021; 15():289-303. PubMed ID: 33531796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topotecan Alleviates Lipopolysaccharide-Mediated Acute Lung Injury Via the NF-κB Signaling Pathway.
    Jin J; Xu W; Wan B; Wang X; Zhou Z; Miao Y; Lv T; Song Y
    J Surg Res; 2019 Mar; 235():83-92. PubMed ID: 30691855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia.
    Wang L; Cao Y; Gorshkov B; Zhou Y; Yang Q; Xu J; Ma Q; Zhang X; Wang J; Mao X; Zeng X; Su Y; Verin AD; Hong M; Liu Z; Huo Y
    Pharmacol Res; 2019 Aug; 146():104292. PubMed ID: 31167111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of resveratrol against acute lung injury induced by lipopolysaccharide via inhibiting the myd88-dependent Toll-like receptor 4 signaling pathway.
    Zhang Z; Chen N; Liu JB; Wu JB; Zhang J; Zhang Y; Jiang X
    Mol Med Rep; 2014 Jul; 10(1):101-6. PubMed ID: 24818579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of IL-17A and IL-17F in lipopolysaccharide-induced acute lung injury and the counteraction of anisodamine or methylprednisolone.
    You QH; Zhang D; Niu CC; Zhu ZM; Wang N; Yue Y; Sun GY
    Cytokine; 2014 Mar; 66(1):78-86. PubMed ID: 24548428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.